Justin Favaro

630 total citations
17 papers, 511 citations indexed

About

Justin Favaro is a scholar working on Molecular Biology, Virology and Oncology. According to data from OpenAlex, Justin Favaro has authored 17 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Virology and 5 papers in Oncology. Recurrent topics in Justin Favaro's work include HIV Research and Treatment (5 papers), RNA Research and Splicing (4 papers) and Virus-based gene therapy research (3 papers). Justin Favaro is often cited by papers focused on HIV Research and Treatment (5 papers), RNA Research and Splicing (4 papers) and Virus-based gene therapy research (3 papers). Justin Favaro collaborates with scholars based in United States and United Kingdom. Justin Favaro's co-authors include Kenneth D. Chavin, Qin L, Paul D. Robbins, Hideaki Tahara, Jonathan S. Bromberg, Yaozhong Ding, Salvatore J. Arrigo, M T Lotze, Tomonari Suzuki and Yanna Ding and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Justin Favaro

16 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Favaro United States 11 253 145 133 124 115 17 511
Vincent Carlier Belgium 12 89 0.4× 55 0.4× 86 0.6× 46 0.4× 198 1.7× 21 476
Scot A. Fahs United States 19 287 1.1× 330 2.3× 81 0.6× 206 1.7× 200 1.7× 35 1.2k
Ryan Schlimgen United States 10 171 0.7× 76 0.5× 28 0.2× 119 1.0× 263 2.3× 11 530
Heinz J. Radzun Germany 14 155 0.6× 27 0.2× 136 1.0× 70 0.6× 196 1.7× 23 498
Sim L. Tung United Kingdom 12 351 1.4× 63 0.4× 163 1.2× 130 1.0× 597 5.2× 15 910
Emilie Castermans Belgium 14 138 0.5× 62 0.4× 77 0.6× 149 1.2× 327 2.8× 21 626
Paula Y. Arnold United States 12 193 0.8× 206 1.4× 103 0.8× 92 0.7× 640 5.6× 22 814
Mirna Koscec United States 12 175 0.7× 100 0.7× 176 1.3× 28 0.2× 274 2.4× 15 643
Tomomitsu Doi Japan 15 271 1.1× 40 0.3× 39 0.3× 127 1.0× 326 2.8× 29 661
Futoshi Hashimoto Japan 8 104 0.4× 41 0.3× 57 0.4× 30 0.2× 279 2.4× 10 502

Countries citing papers authored by Justin Favaro

Since Specialization
Citations

This map shows the geographic impact of Justin Favaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Favaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Favaro more than expected).

Fields of papers citing papers by Justin Favaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Favaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Favaro. The network helps show where Justin Favaro may publish in the future.

Co-authorship network of co-authors of Justin Favaro

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Favaro. A scholar is included among the top collaborators of Justin Favaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Favaro. Justin Favaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bazhenova, Lyudmila, John Hodgson, Corey J. Langer, et al.. (2017). Activity of brigatinib (BRG) in crizotinib (CRZ)-resistant ALK+ NSCLC patients (pts) according to ALK plasma mutation status.. Journal of Clinical Oncology. 35(15_suppl). 9065–9065. 11 indexed citations
2.
Hamilton, E.P., P. Kelly Marcom, Novera Herbert Spector, et al.. (2013). Abstract S4-03: Exome sequencing reveals clinically actionable mutations in the pathogenesis and metastasis of triple negative breast cancer. Cancer Research. 73(24_Supplement). S4–3. 3 indexed citations
3.
Favaro, Justin, et al.. (2013). Introduction to Pharmacology. Medical Entomology and Zoology.
4.
Uronis, Hope E., Johanna C. Bendell, Ivy Altomare, et al.. (2013). A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas. The Oncologist. 18(3). 271–272. 36 indexed citations
5.
Herold, Christina I., Vijaya Chadaram, Bercedis L. Peterson, et al.. (2011). Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing. Clinical Cancer Research. 17(18). 6061–6070. 64 indexed citations
6.
Dugan, Elizabeth M., Kellen L. Meadows, Andrew B. Nixon, et al.. (2010). A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors.. PubMed. 30(4). 1251–6. 3 indexed citations
7.
Hurwitz, Herbert I., et al.. (2006). Long-Term Treatment with Bevacizumab for Patients with Metastatic Colorectal Cancer: Case Report. Clinical Colorectal Cancer. 6(1). 66–69. 14 indexed citations
8.
Favaro, Justin, et al.. (2005). Alk1. 1 indexed citations
9.
Favaro, Justin & Daniel J. George. (2005). Targeted therapy in renal cell carcinoma. Expert Opinion on Investigational Drugs. 14(10). 1251–1258. 11 indexed citations
10.
Favaro, Justin, Frank Maldarelli, Salvatore J. Arrigo, & Michael G. Schmidt. (1999). Effect of Rev on the Cytoplasmic Localization of Intron-Containing Human Immunodeficiency Virus Type 1 RNA. Virology. 255(2). 237–249. 10 indexed citations
11.
Favaro, Justin, et al.. (1999). Activation of a cryptic splice donor in human immunodeficiency virus type-1. Journal of Biomedical Science. 6(1). 45–52. 4 indexed citations
12.
Favaro, Justin, Keith Borg, Salvatore J. Arrigo, & Michael G. Schmidt. (1998). Effect of Rev on the Intranuclear Localization of HIV-1 Unspliced RNA. Virology. 249(2). 286–296. 12 indexed citations
13.
Favaro, Justin & Salvatore J. Arrigo. (1997). Characterization of Rev Function Using Subgenomic and Genomic Constructs in T and COS Cells. Virology. 228(1). 29–38. 13 indexed citations
14.
Borg, Keith, Justin Favaro, & Salvatore J. Arrigo. (1997). Involvement of Human Immunodeficiency Virus Type-1 Splice Sites in the Cytoplasmic Accumulation of Viral RNA. Virology. 236(1). 95–103. 10 indexed citations
15.
L, Qin, Kenneth D. Chavin, Yaozhong Ding, et al.. (1996). Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. The Journal of Immunology. 156(6). 2316–2323. 160 indexed citations
16.
L, Qin, Kenneth D. Chavin, Yanna Ding, et al.. (1995). Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10.. PubMed. 59(6). 809–16. 110 indexed citations
17.
Qin, Lihui, Kenneth D. Chavin, Yaozhong Ding, et al.. (1994). Gene Transfer for Transplantation Prolongation of Allograft Survival with Transforming Growth Factor-β1. Annals of Surgery. 220(4). 508–519. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026